The efficacy and safety of omalizumab in refractory chronic spontaneous urticaria: real-life experience in Turkey


Bulur I., BÜLBÜL BAŞKAN E., Ozdemir M., Balevi A., Goncu E. K., Altunay I., ...More

ACTA DERMATOVENEROLOGICA ALPINA PANNONICA ET ADRIATICA, vol.27, no.3, pp.121-126, 2018 (ESCI) identifier identifier identifier

Abstract

Introduction: This study used real-world data to evaluate the effectiveness and reliability of omalizumab in treating recalcitrant chronic spontaneous urticaria in Turkish patients.